Pfizer has reached agreements with Dexcel Pharma, Hikma Pharmaceuticals and Cipla, regarding lawsuits filed in the U.S. District Court for the District of Delaware. Vyndamax remains the market leader ...

Savvy investors know that change creates opportunities. And a major change is underway at the nation's central bank. Kevin ...

Pfizer announced yesterday it was settling an epic legal battle with the Indian drugmaker Ranbaxy Laboratories that will keep generic versions of the best-selling cholesterol medicine Lipitor off the ...

(Reuters) - U.S. regulators granted Pfizer Inc a reissued patent on its multibillion-dollar Celebrex pain drug that extends its marketing exclusivity until early December 2015, the company said on ...